Treatment with danaparoid during pregnancy for a woman with a cutaneous allergy to low-weight molecular heparin.

被引：0
|
作者：
de Saint-Blanquat, L [1 ]
Simon, L [1 ]
Toubas, MF [1 ]
Hamza, J [1 ]
机构：
[1] Hop St Vincent de Paul, Serv Anesthesie Reanimat Chirurg, F-75014 Paris, France
来源：
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION | 2000年 / 19卷 / 10期
关键词：
cutaneous allergy; danaparoid sodium; pregnancy; LMWH;
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
The authors describe a case of heparin-induced skin reaction due to two preparations of low molecular weight heparin in a pregnant woman. The main characteristics of heparin-related cutaneous allergy are reported. The use of an heparinoid, usually indicated for patients with heparin-induced thrombocytopenia, appeared to be efficient and safe for the mother and her fetus. An epidural analgesia was performed for labor analgesia, 24 hours after the last injection of danaparid of sodium. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码：751 / 754
页数：4
相关论文
共 50 条
  • [31] Thromboprophylaxis with thrombophilia-complicated low molecular weight heparin in pregnancy
    Ebina, Y
    Yamada, H
    Kato, EH
    Yamamoto, R
    Sakuragi, N
    Fujimoto, S
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2002, 28 (05) : 251 - 257
  • [32] Heparin-induced thrombocytopenia with thrombotic complications during prophylactic treatment with low-molecular-weight heparin
    deRaucourt, E
    Vinsonneau, C
    Juvin, K
    Fischer, AM
    Meyer, G
    BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (08) : 786 - 788
  • [33] Women's views on and adherence to low-molecular-weight heparin therapy during pregnancy and the puerperium
    Patel, J. P.
    Auyeung, V.
    Patel, R. K.
    Marsh, M. S.
    Green, B.
    Arya, R.
    Davies, J. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (12) : 2526 - 2534
  • [34] Monitoring of haemocoagulation changes during long-term low molecular weight heparin protection of pregnancy
    Sigutova, P.
    Hajsmanova, Z.
    Slechtova, J.
    Ulcova-Gallova, Z.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1055 - 1055
  • [35] Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review
    Kjaergaard, Amalie Baun
    Fuglsang, Jens
    Hvas, Anne-Mette
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (07) : 824 - 842
  • [36] Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density
    Galambosi, Paivi
    Hiilesmaa, Vilho
    Ulander, Veli-Matti
    Laitinena, Leena
    Tiitinen, Aila
    Kaaja, Risto
    THROMBOSIS RESEARCH, 2016, 143 : 122 - 126
  • [37] Long-term Low-molecular-weight Heparin Therapy during Pregnancy: Is There a Bone Risk?
    Khalifa, Pierre
    Marie-Scemama, Lydia
    THERAPIE, 2013, 68 (01): : 37 - 42
  • [38] Low molecular weight heparin for thromboprophylaxis during caesarean section
    Bonnar, J
    Norris, LA
    Greene, R
    THROMBOSIS RESEARCH, 1999, 96 (04) : 317 - 322
  • [39] Low-molecular-weight heparin (LMWH) in the treatment of thrombosis
    Holzheimer, RG
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2004, 9 (04) : 225 - 239
  • [40] The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy
    Eldor, A
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2002, 104 (01) : 3 - 13
12345